• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

V
V Chantarangkul	-	The Detection of Lupus Anticoagulants in Hemophiliacs: The Need for Different Assay Systems
V Mathews	-	Thirty Novel Mutations in the Factor VIII Gene of Indian Patients with Haemophilia A
v. Mackensen S	-	Quality of Life in Patients with Haemophilia – An European Comparison Study (ESCHQoL)
v. Mackensen S	-	Health-related Quality of Life in Adult Patients with Haemophilia – Assessment with a New Disease-specific Questionnaire (Haem-A-QoL)
v. Mackensen S	-	Quality of Life in Hemophilic Patients without Inhibitors: The Coche Study
v. Mackensen S	-	Assessment of Treatment Satisfaction in Patients with Haemophilia – Development and Validation of the First Disease-Specific Questionnaire (Hemo-SatA)
Vadas MA	-	Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
Vaidyula VR	-	Circulating Tissue Factor Activity Is Increased by Hyperglycemia and Hyperinsulinemia in Normal Human Subjects
Vainchenker W	-	A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis
	-	Apaf-1 and Caspase 9 Regulate Early and Late Stages of Megakaryocyte Differentiation
Vale AAL	-	Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease
Valente S	-	Antiaggreganting Agents Do Not Influence the Sonoclot Profile
	-	High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study
	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
	-	Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes
Valentin N	-	Modulating Murine Platelet Function by Expressing Integrin aIIbb3 Locked-In Its High Affinity State
Valentino L	-	Efficacy and Safety of FEIBA VH Prophylaxis in a Patient with Hemophilia B and a High-Titer Inhibitor
Valentino L	-	Synovitis in a Murine Model of Human Factor VIII Deficiency: Pathology and the Molecular Basis of Disease
Valentino LA	-	Prophylaxis with Factor Eight Inhibitor Bypassing Activity, Vapor Heated (FEIBA VH) Decreases Bleeding Frequency and Maintains or Improves Joint Status
Vallez MO	-	Evaluation of PAI-1 Inhibitors in the Microcirculation of the Hamster Cheek Pouch
Vallvé C	-	The ABO Blood Group Genotype and Factor VIII Levels as Independent Risk Factors for Venous Thromboembolism
Van Aken H	-	Prothrombotic Tendency upon Inflammatory Conditions – Alpha Defensins (HNP-1/2/3) Are Strong Platelet Agonists
	-	New Function for Protease Inhibitors – Alpha1 Antitrypsin and Antithrombin III Inhibit the Activation of Platelets by Alpha Defensins from Neutrophils
Van Bavel E	-	Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia
	-	Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells
Van Belle E	-	Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization
van Berkel ThJC	-	Platelet Activation by Oxidized Low-Density Lipoprotein Is Mediated by CD36 and Scavenger Receptor-A
van Beurden-Lourenssen GJACM	-	Administration of Recombinant Activated Factor VII Causes Activation of Integrin aIIbb3 on Blood Platelets both in vivo and in vitro, Lowering the Threshold for Activation by Thrombin
Van Cott EM	-	Massive Sinus Thrombosis in a Six-Year-Old Girl: Acute Management and Identification of a Possible New Hypercoagulable State
Van Cott E	-	Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP)
van de Kar NCAJ	-	Predictive Value of the Platelet Function Analyser (PFA-100®) for Post Biopsy Bleedings in Patients Undergoing Renal Biopsy
Van de Poel MHW	-	Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
Van de Poel MH	-	A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
Van de Poel MHW	-	The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia
van de Velde A	-	Characterisation and Classification of Von Willebrand Diseases
van de Ven AJAM	-	Malaria Infection Induced Thrombocytopenia Is not Related to Systemic Platelet Activation
Van de Walle G	-	Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin
Van de Walle G	-	Different Active Conformations Are Induced in the Collagen Receptor Integrin a2b1 by Outside Manipulation and Inside-out Signalling
Van de Walle G	-	Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation
Van de Water NS	-	ZPI Gene Mutations and Myocardial Infarction
Van de Werf F	-	Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
van Delden OM	-	Alternative Clinical Diagnoses with Spiral CT in Patients with Suspected Pulmonary Embolism
Van den Berg HM	-	Influence of Type of Factor VIII Gene Mutation on Inhibitor Development in a Single Centre Cohort of Severe Haemophilia a Patients
van den Berg E	-	Early Anticoagulation for Prevention and Therapy of Deep Venous Thrombosis In Patients Undergoing Craniotomy For Brain Tumor – Risk of Postoperative Intra-cranial Hemorrhage in a Prospective Long-term Study
van den Berg HM	-	Factor VIII Inhibitors in Hemophilia A during Immune Tolerance Induction
Van den Berg HM	-	Late Prophylaxis for Severe Hemophilia: Effects of Prophylaxis Started in Adulthood
Van den Berg E	-	Perioperative Prophylaxis Against Thromboembolism in Patients Undergoing Craniotomy for Brain Tumor: Analysis of Efficacy of Early Low Molecular Weight Heparin
Van den Berg HM	-	Increased Fibrinolytic Activity in Patients with a More Severe Clinical Phenotype of Severe Hemophilia A
Van den Besselaar AMHP	-	Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy
van den Besselaar AMHP	-	INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins
	-	Results of the Master Lot Calibration of a New Coagulation Monitoring System for Patient Self Testing
van den Biggelaar M	-	Intracellular Assembly of Factor VIII and von Willebrand Factor
Van den Brink R	-	Thromboembolic and Bleeding Complications during Non-cardiac Surgery in Patients with Mechanical Heart Valves
Van der Bom JG	-	Increased Fibrinolytic Activity in Patients with a More Severe Clinical Phenotype of Severe Hemophilia A
van der Bom JG	-	Hemorrhagic risk in Female Carriers of Hemophilia
Van der Bom JG	-	Influence of Type of Factor VIII Gene Mutation on Inhibitor Development in a Single Centre Cohort of Severe Haemophilia a Patients
Van der Elst L	-	Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity
van der Heide Y	-	Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes
Van der Heijde D	-	Rofecoxib (Vioxx) Increases Thrombin Generation in Platelet Rich Plasma
Van der Linden S	-	Rofecoxib (Vioxx) Increases Thrombin Generation in Platelet Rich Plasma
Van der Meer J	-	A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
	-	A Prospective Study to Assess the Absolute Incidence of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin and the Contribution of Cosegregation of Other Thrombophilic Defects
van der Meer J	-	Clinical Implications of Individual Time Within Target Range (ITTR) in Patients with Atrial Fibrillation (AF) treated with Vitamin K Antagonists
	-	Fetal Loss in Hereditary Antithrombin, Protein C and Protein S Deficiencies
	-	The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia
van der Meer RW	-	Right Ventricular Dysfunction and the Pulmonary Obstruction Index Assessed with Helical CT Predict Clinical Outcome During Three-month Follow-up in Patients with Acute Pulmonary Embolism
van der Meer FJM	-	Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
Van der Meer J	-	Protein C/S Ratio to Identify Protein S Type I Non-Deficient Relatives at High Risk of Venous Thromboembolism (VTE). Results from a Family Cohort Study (DESCARTES)
	-	Effects of Highly Active Antiretroviral Therapy on the Risk of Venous and Arterial Thromboembolism in Male and Female HIV Positive Patients
	-	High Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies of Protein S, Protein C or Antithrombin Is Due to Acceleration Rather Than Overall Increased Risk. A Retrospective Family Cohort Study (DESCARTES)
van der Meer J	-	Individual Time within Target Range (ITTR), an Accurate Predictor of Clinical Outcome in Patients with Acute Myocardial Infarction (AMI) Treated with Vitamin K Antagonists
Van der Meer J	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S or Antithrombin Strongly Depends on Cosegregation of other Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
	-	Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies Of Protein S, Protein C or Antithrombin Strongly Depends on Cosegregation of Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
	-	Hereditary Deficiencies of Protein C, Protein S And Antithrombin Protect Against Bleeding During Anticoagulant Treatment. Results from a Family Cohort Study (DESCARTES)
van der Meer J	-	Reduction of Fetal Loss Rate by Anticoagulant Treatment during Pregnancy in Women with Hereditary Deficiency of Antithrombin, Protein C or Protein S Type I. A Prospective Study
	-	Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
van der Meer FJM	-	Subtherapeutic Oral Anticoagulant Therapy – Frequency and Risk Factors
Van der Meer J	-	Low CD4/CD8 Ratios In HIV Negative Haemophilia Patients Cause High HCV Viraemia
van der Meer J	-	Risk of Thromboembolic Events and Major Bleeding in Patients Treated with Vitamin K Antagonists after Heart Valve Replacement (HVR); Individual Time within Target Range (ITTR) an Accurate Predictor
Van Der Meer FJM	-	Comparison between Two Computer Algorithms in Oral Anticoagulant Dosage – A Doubleblind Randomised Controlled Trial
	-	A Randomised Controlled Trial Comparing Warfarin and Phenprocoumon on Quality of Oral Anticoagulant Treatment
Van der Meer J	-	Protein C/S Ratio Improves Accuracy to Identify Hereditary Protein S Deficiency Type I. Results from a Family Cohort Study (DESCARTES)
	-	Absolute Risk of Arterial Thromboembolism (ATE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
van der Meer J	-	The Incidence of Venographically Detected Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
Van der Meer J	-	Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c
	-	Risk of Recurrent Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin Depends on Cosegregation with Other Thrombophilic Disorders: A Prospective Family Cohort Study
	-	Hereditary Deficiencies of Protein C, Protein S or Antithrombin Are No Risk Factors for Arterial Thromboembolism (ATE). Results from a Large Family-Cohort Study (DESCARTES)
Van der Meijden PEJ	-	P2Y12 Receptor Stimulation Prolongs Thrombin-Induced Calcium Responses and Procoagulant Activity Via Novel Signaling Pathways; Variable Effect of Clopidogrel Treatment
van der Meijden PEJ	-	Disclosure of Microdomain Structure and Function in Arterial Thrombi of Heterogeneous Composition
Van der Meulen PA	-	Effects of Highly Active Antiretroviral Therapy on the Risk of Venous and Arterial Thromboembolism in Male and Female HIV Positive Patients
van der Planken M	-	Pretreatment with Aspirin and Loading Dose Clopidogrel Obviates the Need for Glycoprotein Iib/Iiia Antagonists During Elective Coronary Stenting
	-	Characterisation and Classification of Von Willebrand Diseases
Van der Poel MHW	-	Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c
	-	Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
van der Poll T	-	Endogenous Tissue-Type Plasminogen Activator Is Essential for an Adequate Host Defense During Induced Abdominal Sepsis
	-	Local Attenuation of the Protein C Pathway in Patients Developing Pneumonia
	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
	-	Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs
	-	Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans
	-	Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Influences the Inflammatory But Not the Procoagulant/Fibrinolytic Response to Escherichia coli-Induced Abdominal Sepsis in Mice
van der Putten HHAGM	-	The Prothrombin G19911A Is a Functional Non-coding Polymorphism
Van der Schaaf W	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S or Antithrombin Strongly Depends on Cosegregation of other Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
	-	Hereditary Deficiencies of Protein C, Protein S And Antithrombin Protect Against Bleeding During Anticoagulant Treatment. Results from a Family Cohort Study (DESCARTES)
	-	A Prospective Study to Assess the Absolute Incidence of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin and the Contribution of Cosegregation of Other Thrombophilic Defects
	-	Risk of Recurrent Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin Depends on Cosegregation with Other Thrombophilic Disorders: A Prospective Family Cohort Study
	-	Hereditary Deficiencies of Protein C, Protein S or Antithrombin Are No Risk Factors for Arterial Thromboembolism (ATE). Results from a Large Family-Cohort Study (DESCARTES)
Van Der Schueren B	-	Angiographic Documentation of the Efficacy of Recombinant Activated Factor VII (Novo Seven) to Control Diffuse Bleeding in Major Trauma
van der Sluijs KF	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
van der Spoel JI	-	The Diagnosis and the Estimated Incidence of Heparin-Induced Thrombocytopenia in the Critically Ill According to ISTH SSC Criteria
Van der Velde EF	-	Reliability and Interobserver Variability of the Simplify® D-Dimer Assay for Detecting D-Dimers in Capillary Blood
van der Vleuten GM	-	A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest
van der Voort D	-	Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography
	-	ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice
	-	Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice
van der Wal AC	-	Impaired Thrombus Formation after Sterile Inflammation Induced by Endotoxin in a Murine Carotid Artery Thrombosis Model
van der Zee PM	-	P-selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction
van der Zwaan C	-	Clusters of Ligand-Binding Domains of Low-density Lipoprotein Receptor-related Protein Bind both Heavy and Light Chain of Activated Factor V and Inhibit Cofactor Function
	-	Functional Duplication of Ligand-Binding Domains within Low-Density Lipoprotein Receptor-Related Protein for Interaction with Alpha2-Macroglobulin, Factor IXa and Factor VIII
	-	An Antibody Fragment Against Factor VIII That inhibits Factor VIII assembly with von Willebrand Factor and LDL Receptor Family Members
van Diemen-Homan JEM	-	Hemorrhagic risk in Female Carriers of Hemophilia
Van Dijk K	-	Influence of Type of Factor VIII Gene Mutation on Inhibitor Development in a Single Centre Cohort of Severe Haemophilia a Patients
	-	Late Prophylaxis for Severe Hemophilia: Effects of Prophylaxis Started in Adulthood
	-	Increased Fibrinolytic Activity in Patients with a More Severe Clinical Phenotype of Severe Hemophilia A
Van Dongen CJ	-	Thromboembolic and Bleeding Complications during Non-cardiac Surgery in Patients with Mechanical Heart Valves
	-	Reliability and Interobserver Variability of the Simplify® D-Dimer Assay for Detecting D-Dimers in Capillary Blood
van Dongen CJ	-	C-reactive Protein in Combination with Clinical Decision Rule and D-Dimer to Safely Rule out Pulmonary Embolism
van Dongen MC	-	Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project
van Dongen C	-	Predictors of Recurrent Venous Thromboembolism. Balancing Benefits and Risks – A Decision Approach
Van Dongen MC	-	Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project
van Dongen CJ	-	Clinical Usefulness of Prothrombin Fragment 1+2 in Patients with Suspected Pulmonary Embolism
van Doornum GJ	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
Van Doren S	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Van Dreden P	-	High Concentrations of Procoagulant Microparticles in Patients with Multiple Trauma
	-	Protein Z and the Protein C System in Normal Pregnancies and Patients with Early Foetal Loss
van Eck ATCJ	-	Perioperative Prophylaxis Against Thromboembolism in Patients Undergoing Craniotomy for Brain Tumor: Analysis of Efficacy of Early Low Molecular Weight Heparin
van Eck M	-	Platelet Activation by Oxidized Low-Density Lipoprotein Is Mediated by CD36 and Scavenger Receptor-A
van Eck ATCJ	-	Early Anticoagulation for Prevention and Therapy of Deep Venous Thrombosis In Patients Undergoing Craniotomy For Brain Tumor – Risk of Postoperative Intra-cranial Hemorrhage in a Prospective Long-term Study
van Eeden S	-	Imaging of Highly Organized Vitronectin-Vimentin Polymeric Complexes that Express on the Surface of Activated Platelets and Platelet Microparticles using Atomic Force Microscopy
van Erpecum KJ	-	Childhood Acquired Hepatitis C Infection in Patients with Hemophilia: A Cohort Study
Van Geest-Daalderop JHH	-	Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy
Van Geet C	-	Impaired Platelet Adhesion on Collagen Surfaces and Secretion Defect in Duchenne Muscular Dystrophy Patients
	-	Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G-protein Signaling 2 (RGS2)
	-	The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure
van Genderen H	-	Annexin A5 Regulates the Engulfment Protein Repertoire on the Membrane of PS Expressing Apoptotic Cells
Van Genderen H	-	Apoptosis of Monocytes Reduces Their Interaction with P-Selectin Expressing Platelets Under Flow Conditions by Disruption of the Interaction of PSGL-1 with the Actin Cytoskeleton
van Goor MPJ	-	Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation?
van Gorp E	-	Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism
van Gorp ECM	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
van Haeften T	-	Impaired Insulin Signaling in Platelets from Patients with Diabetes Mellitus Type 2
	-	Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2
van Haeften TW	-	Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers
van Haren BJT	-	von Willebrand Factor in Platelets
van Haren B	-	DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N
van Heerde WL	-	Relevance of Very Low Titres of Factor VIII Inhibitors in Nijmegen-Bethesda Assay-Negative Patients
	-	DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N
	-	13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population
van Heerde WL	-	The Nijmegen Hemostasis Assay Is a Useful Tool to Screen Thrombophilia
van Heerde WL	-	The Nijmegen Haemostasis Assay to Study the Interplay between Coagulation and Fibrinolysis
van Heerde WL	-	The Importance of the Low-Density Lipoprotein Receptor-Related Protein (LRP) and Megalin Receptor in the Clearance of Factor VIII in Humans
	-	Administration of Recombinant Activated Factor VII Causes Activation of Integrin aIIbb3 on Blood Platelets both in vivo and in vitro, Lowering the Threshold for Activation by Thrombin
	-	Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII
van Heerde WL	-	Malaria Infection Induced Thrombocytopenia Is not Related to Systemic Platelet Activation
van Heerde WL	-	Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients
	-	von Willebrand Factor in Platelets
van Heerde WL	-	The Effect of Statin Therapy on Coagulation and Fibrinolysis in Patients with Heterozygous Familial Hypercholesterolemia
	-	The Role of Annexin A5 and Anti-Annexin A5 Antibodies in the Antiphospholipid Syndrome
	-	Determination of Platelet Activation Biomarkers Using the Surface Enhanced Laser Desorption/Ionisation Time of Flight (SELDI-TOF) Proteomic Approach
van Heerde WL	-	Screening Fibrinolytic Disorders with the Nijmegen Haemostasis Assay
	-	Laboratory Identification of Severe Haemophilia Is APTT-Reagent Dependent
Van Hees L	-	The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure
van Hees T	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
van Helden PMW	-	Factor VIII Inhibitors in Hemophilia A during Immune Tolerance Induction
van Hinsbergh VWM	-	Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and Pancreatic Carboxypeptidase B (CPB) on the Capillary Tube Formation in an in vitro Angiogenesis System
van Hoogen PCM	-	The Importance of the Low-Density Lipoprotein Receptor-Related Protein (LRP) and Megalin Receptor in the Clearance of Factor VIII in Humans
Van kerckhoven S	-	P-selectin Antagonist Gallic Acid is Antithrombotic Via Inhibition of Circulating Tissue Factor Deposition in Developing Murine Arterial Thrombi
van Korlaar IM	-	Attitudes about Genetic Testing for Thrombophilia in a Large Family with Heritable Protein C Deficiency
van Kraaij mgJ	-	The Nijmegen Hemostasis Assay Is a Useful Tool to Screen Thrombophilia
van Kraaij MGJ	-	13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population
	-	Relevance of Very Low Titres of Factor VIII Inhibitors in Nijmegen-Bethesda Assay-Negative Patients
van Kraaij M	-	DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N
van Kraaij MGJ	-	The Importance of the Low-Density Lipoprotein Receptor-Related Protein (LRP) and Megalin Receptor in the Clearance of Factor VIII in Humans
	-	Administration of Recombinant Activated Factor VII Causes Activation of Integrin aIIbb3 on Blood Platelets both in vivo and in vitro, Lowering the Threshold for Activation by Thrombin
van Kraaij M	-	The Nijmegen Haemostasis Assay to Study the Interplay between Coagulation and Fibrinolysis
van Kraaij MGJ	-	Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII
van Kraaij mgJ	-	Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients
van Kraaij MGJ	-	Screening Fibrinolytic Disorders with the Nijmegen Haemostasis Assay
	-	von Willebrand Factor in Platelets
Van Leeuwen Y	-	Comparison between Two Computer Algorithms in Oral Anticoagulant Dosage – A Doubleblind Randomised Controlled Trial
	-	A Randomised Controlled Trial Comparing Warfarin and Phenprocoumon on Quality of Oral Anticoagulant Treatment
van Lier M	-	Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow
van Lieshout MHP	-	Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers
Van Lummel M	-	Interaction of Beta2-Glycoprotein I with Members of the Low-density Lipoprotein Receptor (LDLR) Super Family
van Lummel M	-	Platelet Adhesion to Dimeric Beta2-Glycoprotein-I Under Conditions of Flow Is Mediated by Glycoprotein Iba
Van Lummel M	-	C-Terminal Domain of Beta2-Glycoprotein I Is Involved in Binding to Apoer2'
Van Marion V	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
van MierloBüller PJWBHR	-	Diagnostic Strategy Using a Modified Clinical Decision Rule and D-Dimer Test to Rule Out Pulmonary Embolism in Elderly in- and Outpatients
van Minkelen R	-	The Marburg I Polymorphism of Factor Seven-Activating Protease Is Not Associated with Venous Thrombosis
	-	Interleukin 1 Haplotypes and the Risk of Venous Thrombosis
van Mourik JA	-	Protein Kinase A-dependent Clustering of Weibel-Palade Bodies in Endothelial Cells
	-	Von Willebrand Factor-mediated Sorting of Endothelial Secretory Proteins
Van Noorden CR	-	Effect of Modified Normothrombotic Heparin on Cancer Progression and Metastasis
van Oerle R	-	ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice
	-	Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography
	-	Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes
	-	Analysis of Blood Coagulation in Mice: Pre-analytical Conditions and Comparison of a Home-made Assay for Thrombin-antithrombin Complexes with Two Commercial Assays
Van Oerle R	-	Activity and Localization of Tissue Factor and Factor VII in Organs of Normal and Endotoxemic Mice
van Oerle R	-	Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State
	-	A Hypercoagulable State in Myeloperoxidase Deficient Mice
Van Oerle R	-	Platelet Derived Microparticles in Blood Bank Products Do Not Expose Functionally Active Tissue Factor But Are Highly Procoagulant
van Oerle R	-	Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice
van Ommen CH	-	Clinical Experience with Nadroparin in Pediatric Patients with Venous Thrombosis
van Pampus ECM	-	Integrins Mediate Shedding of Procoagulant Microparticles at Minimal Platelet Activation
	-	Plasma Ecto-NTPDase Prevents Platelet P2X1 and P2Y12 Receptor Desensitization During Storage
Van Raak EPM	-	P2Y12 Receptor Stimulation Prolongs Thrombin-Induced Calcium Responses and Procoagulant Activity Via Novel Signaling Pathways; Variable Effect of Clopidogrel Treatment
van Rijn JC	-	Alternative Clinical Diagnoses with Spiral CT in Patients with Suspected Pulmonary Embolism
Van Stempvoort G	-	The Contribution of Somatic Mutations in an Antibody against Factor VIII to the Kinetics of Factor VIII Binding and Inhibition of Factor VIII Activity
Van Stralen KJ	-	Upper Extremity Venous Thrombosis; Risk estimations for Surgery, Plaster Cast, Unusual Activities and Exercise
	-	Effect of Regular Sports Activities on the Risk of Venous Thrombosis: Results from the MEGA Study
van Strijen MJL	-	Right Ventricular Dysfunction and the Pulmonary Obstruction Index Assessed with Helical CT Predict Clinical Outcome During Three-month Follow-up in Patients with Acute Pulmonary Embolism
van t Veer C	-	Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Influences the Inflammatory But Not the Procoagulant/Fibrinolytic Response to Escherichia coli-Induced Abdominal Sepsis in Mice
van Tilburg NH	-	The Effect of ABO Blood Group Genotypes on the Loading of von Willebrand Factor with A and B Antigens
van Tits LJ	-	The Effect of Statin Therapy on Coagulation and Fibrinolysis in Patients with Heterozygous Familial Hypercholesterolemia
van Veen JJ	-	Reproducibility of the Endogenous Thrombin Potential by Calibrated Automated Thrombogram Assay
	-	Clinical Use of Protamine for the Emergency Reversal of Anticoagulation with Low Molecular Weight Heparin (LMWH)
van Vliet H	-	Characterisation and Classification of Von Willebrand Diseases
van Vliet HHDM	-	Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation?
van Vlijmen BJM	-	Clearance of Plasminogen Activator Inhibitor-1 in Low-Density Lipoprotein Receptor-Related Protein Deficient Mice
Van Vlijmen EFW	-	High Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies of Protein S, Protein C or Antithrombin Is Due to Acceleration Rather Than Overall Increased Risk. A Retrospective Family Cohort Study (DESCARTES)
	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies Of Protein S, Protein C or Antithrombin Strongly Depends on Cosegregation of Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
Van Weert HC	-	Reliability and Interobserver Variability of the Simplify® D-Dimer Assay for Detecting D-Dimers in Capillary Blood
van Zandvoort MAMJ	-	Crucial Role of Glycoprotein VI in Thrombus Formation and Coagulation during Venous and Arterial Thrombosis
	-	Disclosure of Microdomain Structure and Function in Arterial Thrombi of Heterogeneous Composition
van Zanten AP	-	Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes
Vana L	-	Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects
Vandekerckhove J	-	Protein Profiling of Human Blood Platelets from Young and Aged Individuals
Vandendries ER	-	Maximal Platelet Accumulation, But Not Fibrin Deposition, Is Dependent on Protease-Activated Receptor 4 in a Mouse Model of Thrombosis
VanderPost J	-	Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia
	-	Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells
Vandervoort PAH	-	Domain A1 in Unfolded von Willebrand Factor Can Recruit Flowing Platelets to Collagen Surfaces Independently of Domain A3
Vandhuick O	-	Premature Atherosclerosis in HIV Positive Patients and Cumulated Time of Exposure to Antiretroviral Therapy (SHIVA Study)
Vanhaeverbeek M	-	Circulating Platelet-Monocyte Complexes Are Inversely Correlated with Serum Apo-A Levels
Vanhoorelbeke K	-	A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype
Vanhoorelbeke K	-	A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia
	-	Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody
	-	Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis
	-	Different Active Conformations Are Induced in the Collagen Receptor Integrin a2b1 by Outside Manipulation and Inside-out Signalling
	-	Non-helical Peptide Sequence SRHPRVGVYHVFDSA Binds Specifically to Human Integrin a2b1
	-	Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing
	-	Shielding of the A1-Domain by the Amino-Terminal Domain (AA764–1035) of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V
	-	Production of Anti-ADAMTS-13 Monoclonal Antibodies by DNA Immunization
	-	False Positives Account For Low Conversion Frequency In Chimeraplasty For Von Willebrand Disease
	-	Combination of Loss of Function of Recombinant R1334A-VWF and Gain of Function of R1336A-VWF Results in a Loss of Function of RKR1334-1335-1336A-VWF
	-	Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation
Vanier M-C	-	Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial)
Vannier JP	-	The Stable Prostacyclin Analog Iloprost Induces The Production of the Angiogenic Factor Oncostatin M by Monocytes in a p38K-dependent Pathway
	-	S6-Kinase as a Possible Target for the Angiogenic Activity of Interleukin-4
van't Hof AWJ	-	Role of Platelet Aggregation Testing in Acute Stent Thrombosis
van't Veer C	-	Low Molecular Weight Heparin Attenuates Multiorgan Failure in DIC
	-	Endogenous Tissue-Type Plasminogen Activator Is Essential for an Adequate Host Defense During Induced Abdominal Sepsis
Vanyusheva OV	-	Study of the Methylenetetrahydrofolate Reductase Gene Promoter in Patients With Heterozygous C677T MTHFR Gene Polymorphism and Hyperhomocysteinemia
Vanzan A	-	The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study
Váradi B	-	Modulation of Fibrinolysis by Some Components Present in Arterial Thrombus
Varadi K	-	The Effects of Supra-Normal Protein C Levels on Markers of Coagulation, Fibrinolysis and Inflammation in a Human Model of Endotoxemia
Váradi K	-	TECHNOTHROMBIN® TGA a Novel Thrombin Generation Assay Suitable for the New Routine Coagulation Analyzer Ceveron® Alpha
	-	Protective Effect of Human Plasma-Derived Protein C in Septic Neonatal Mice
Varakin Ya	-	Platelet Function in Patients with Cerebrovascular Pathology in Changes of Geomagnetic Field of Earth
Varcoe R	-	The Circulating Progenitor in Intimal Hyperplasia: Could It Be the Fibrocyte?
Vardimon H	-	A New Approach for Pre Analytical Screening of Hospitalized Patients Receiving Anticoagulant Therapy
Varfolomeyev SD	-	Fibrin-Monomer Prepared Using Thrombin-Like Enzyme from Snake Venom Agkistrodon Halys as Stimulator of Plasminogen Activation By t-PA
	-	Inhibition Kinetics of Plasmin-staphylokinase (Pm-STA) and Plasmin-Streptokinase (Pm-SK) Complexes with Different Protein Inhibitors
	-	Activation Kinetics of Glycoform of GLU-Plasminogen and Lys-Plasminogen by Plasmin-Staphylokinase Complex
Vargová K	-	Statins Do Not Interfere with the Antiplatelet Effect of Loading Dose Clopidogrel in Patients with Ischemic Heart Disease
Varlack S	-	Glucose Uptake Via GLUT3 in Human Platelets Is Regulated Via PKB
Varma S	-	Prevalence of Risk Factors for Venous Thromboembolism: A Study from North India
Varon D	-	Platelet-Derived Microparticles Induce Angiogenesis and Stimulate Post-Ischemic Revascularization
	-	Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results
	-	Platelet Mediated Clot Formation in Whole Blood under Flow: A New Screening Method for Coagulation Disorders and for Drug Monitoring
	-	Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome
Varon D	-	Dynamic Responsiveness to Aspirin in Patients Undergoing PCI
Varon D	-	High Rate of Unresponsiveness to Clopidogrel in Patients with Acute Coronary Syndrome (ACS) As Determined by the Impact-R [Cone And Plate(let) Analyzer]
	-	Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome
	-	CRP Induces Platelet-Endothelial Adhesion Under Flow
Vartholomatos G	-	Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis
	-	Assessing Acquired and Inherited Factors in Cases of Idiopathic and Secondary Pulmonary Embolism
Vartholomatos G	-	Is Screening for Thrombophilia Mutations Necessary Prior to Free Functional Muscle Transfer?
Varughese KI	-	Modulation of Von Willebrand Factor A1 Domain-Mediated Platelet Aggregation by a-Thrombin
Varvenne M	-	Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia
Vasilchuk G	-	The Role of Mild Forms of Coagulopathias and Pathology of Platelets in the Development of Menorrhagia and Metrorrhagia
	-	The Role of Mild Forms of Coagulopathias and Pathology of Platelets in the Development of Menorrhagia and Metrorrhagia
Vasiliadis N	-	An Inquiry into Death Causes Based on Autopsy Findings
Vasiljevic Z	-	Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years
Vasovic V	-	RNA Interference Targeting Tissue Factor in a Murine Melanoma Metastasis Model
Vasquez J	-	Investigation of Performance and Sample Interferences for a New Automated Protein S Functional Activity Assay (HemosIL ProS)
Vasse M	-	S6-Kinase as a Possible Target for the Angiogenic Activity of Interleukin-4
	-	The Stable Prostacyclin Analog Iloprost Induces The Production of the Angiogenic Factor Oncostatin M by Monocytes in a p38K-dependent Pathway
Vassiliou M	-	Assessing Acquired and Inherited Factors in Cases of Idiopathic and Secondary Pulmonary Embolism
Vaughan DE	-	PAI-1 and Atherothrombosis
Vauterin S	-	Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing
	-	Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis
	-	Non-helical Peptide Sequence SRHPRVGVYHVFDSA Binds Specifically to Human Integrin a2b1
	-	Production of Anti-ADAMTS-13 Monoclonal Antibodies by DNA Immunization
Vavilova T	-	The New Single Nucleotide Polymorphisms of Adp Receptor P2y12 Gene Affected Platelet Aggregation and Myocardial Infarction Development Were Found in Russia
Vavilova T	-	Inherited Thrombophilias in the Patients with Prosthetic Heart Valves
	-	Pharmacogenetics of Warfarin–Cytochrome Cyp2c9 and Vitamin K Epoxide Reductase Gene Polymorphisms in Russian Population
Vayá A	-	Protein CValencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
	-	Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
Vayro S	-	Tissue Factor Synthesis and Expression by Human Proximal Tubular Cells: the Source of Increased Urinary Tissue Factor Secretion in Disease?
Vaz FAC	-	Thromboembolic Complications of Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: Effects of the Disease and the Therapy on the Hemostatic System
Vaz MLS	-	Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss
Vázquez-González G	-	Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit
Vdovin VV	-	Ulcerous Colitis in Children with Hemophilia A
Vdovin V	-	The State of Fibrinolytic and Coagulation Systems in Hemophiliacs
	-	The Occasions of Factor XII Deficiency in Children
Veber B	-	Heparin-PF4 Elisa Antibodies Detection Is Not Relevant to Diagnose HIT During Sepsis
Vecchioli M	-	Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
Vecchione G	-	Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
Vedovati MC	-	High Incidence of Bilateral Deep Vein Thrombosis in Cancer Patients
Veeger NJGM	-	Risk of Recurrent Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin Depends on Cosegregation with Other Thrombophilic Disorders: A Prospective Family Cohort Study
	-	Hereditary Deficiencies of Protein C, Protein S or Antithrombin Are No Risk Factors for Arterial Thromboembolism (ATE). Results from a Large Family-Cohort Study (DESCARTES)
Veeger NJ	-	Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c
Veeger NJGM	-	Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
	-	Reduction of Fetal Loss Rate by Anticoagulant Treatment during Pregnancy in Women with Hereditary Deficiency of Antithrombin, Protein C or Protein S Type I. A Prospective Study
	-	Protein C/S Ratio Improves Accuracy to Identify Hereditary Protein S Deficiency Type I. Results from a Family Cohort Study (DESCARTES)
Veeger NJGM	-	Risk of Thromboembolic Events and Major Bleeding in Patients Treated with Vitamin K Antagonists after Heart Valve Replacement (HVR); Individual Time within Target Range (ITTR) an Accurate Predictor
Veeger NJGM	-	The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia
Veeger NJGM	-	Clinical Implications of Individual Time Within Target Range (ITTR) in Patients with Atrial Fibrillation (AF) treated with Vitamin K Antagonists
Veeger NJGM	-	Fetal Loss in Hereditary Antithrombin, Protein C and Protein S Deficiencies
	-	A Prospective Study to Assess the Absolute Incidence of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin and the Contribution of Cosegregation of Other Thrombophilic Defects
	-	Protein C/S Ratio to Identify Protein S Type I Non-Deficient Relatives at High Risk of Venous Thromboembolism (VTE). Results from a Family Cohort Study (DESCARTES)
	-	High Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies of Protein S, Protein C or Antithrombin Is Due to Acceleration Rather Than Overall Increased Risk. A Retrospective Family Cohort Study (DESCARTES)
Veeger NJGM	-	Individual Time within Target Range (ITTR), an Accurate Predictor of Clinical Outcome in Patients with Acute Myocardial Infarction (AMI) Treated with Vitamin K Antagonists
Veeger NJGM	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies Of Protein S, Protein C or Antithrombin Strongly Depends on Cosegregation of Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
Veeger NJ	-	Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
Veeger NJGM	-	Hereditary Deficiencies of Protein C, Protein S And Antithrombin Protect Against Bleeding During Anticoagulant Treatment. Results from a Family Cohort Study (DESCARTES)
	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S or Antithrombin Strongly Depends on Cosegregation of other Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES)
VeegerBüller NHR	-	The Incidence of Venographically Detected Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
Vega-Ostertag ME	-	Induction of Tolerance to b2Glycoprotein I in Mice
	-	A Monoclonal Anti-C5 Antibody Reverses Antiphospholipid Antibody-mediated Thrombosis
Vega-Ostertag ME	-	A Peptide Derived from Cytomegalovirus Reverses Antiphospholipid-Mediated Thrombosis by Displacing Binding of b2glycoprotein I to Endothelial Cells in Mice
Vega-Ostertag ME	-	Toll Like Receptor 4 Is Involved in Antiphospholipid-mediated Thrombosis: In vivo Studies
	-	Antiphospholipid Antibodies Impair the Clearance of Apoptotic Platelets
Vegh P	-	Comparison of the Anticoagulant Effects of Melagatran and LMWH in an Acquired Antithrombin Deficiency in Children with ALL Treated with L-Asparaginase: An Ex Vivo Study
	-	No Difference in Incidences of Thrombosis between Heparin Bonded Catheters and Non Heparin Bonded Catheters in Infants in the Critical Care Unit Following Surgery for Congenital Heart Disease: A Randomised Controlled Triple Blind Study
Veglia F	-	Platelet Associated Tissue Factor Expression in Patients with Antiphospholipid Syndrome
Vekaria R	-	Prothrombin Binding to Phospholipid Membranes – A Proposed Mechanism
Vekris M	-	Is Screening for Thrombophilia Mutations Necessary Prior to Free Functional Muscle Transfer?
Velásquez H	-	Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions
Veldman A	-	Effect of Protein C and Activated Protein C on Alveolar Fibrin Deposition and Turnover in a Piglet Model of Septic Shock
Veljkovic D	-	Pediatric Thrombosis
Venco A	-	The Risk of Venous and Arterial Thrombosis in Patients with HIV Infection
	-	D-Dimer and the Risk of Venous Thromboembolism in Medical Patients
	-	Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study
	-	D-Dimer Measurement after Acute Ischemic Stroke Does Not Predict Long Term Outcome Events
	-	Prevalence of the Metabolic Syndrome in Patients with Provoked or Unprovoked Deep Vein Thrombosis and in Controls
Venge P	-	Nitric Oxide Enhances Eosinophil and Basophil Degranulation without Affecting Contact and Complement Activation
Vengust R	-	Methyl-Methacrylate Bone Cement Surface Does Not Promote Platelet Aggregation or Plasma Coagulation in vitro
Ventura C	-	The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients
Venz S	-	Proteomics as a Tool for Assessment of Therapeutics in Transfusion Medicine: Evaluation of Prothrombin Complex Concentrates
Vera E	-	Determination of ADAMTS-13 Activity in 13 Patients with Ischemic Stroke
	-	Genetic Study of von Willebrand Factor in Twenty-two Members of an Argentinian Family
	-	Partial Purification of ADAMTS-13
Vera E	-	Von Willebrand Factor and ADAMTS-13 in 23 Doberman Pinschers Dogs
Verbeek K	-	13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population
Verbeuren TJ	-	Silencing of Plasminogen Activator Inhibitor-1 by Small Interfering RNA Increases the Expression of Tissue Plasminogen Activator
	-	Evaluation of PAI-1 Inhibitors in the Microcirculation of the Hamster Cheek Pouch
Verbruggen H	-	Platelet Function Analyser Is a Good Alternative for Classical Bleeding Time to Detect von Willebrand Disease and Thrombocytopathy
	-	Determination of Platelet Activation Biomarkers Using the Surface Enhanced Laser Desorption/Ionisation Time of Flight (SELDI-TOF) Proteomic Approach
	-	von Willebrand Factor in Platelets
Verbruggen HW	-	Laboratory Identification of Severe Haemophilia Is APTT-Reagent Dependent
Verbruggen H	-	Screening Fibrinolytic Disorders with the Nijmegen Haemostasis Assay
Verbruggen HW	-	13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population
Verbruggen HW	-	Relevance of Very Low Titres of Factor VIII Inhibitors in Nijmegen-Bethesda Assay-Negative Patients
Verbruggen H	-	DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N
	-	The Nijmegen Hemostasis Assay Is a Useful Tool to Screen Thrombophilia
Verbruggen HW	-	Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII
Verbruggen H	-	The Nijmegen Haemostasis Assay to Study the Interplay between Coagulation and Fibrinolysis
Verbruggen HW	-	Predictive Value of the Platelet Function Analyser (PFA-100®) for Post Biopsy Bleedings in Patients Undergoing Renal Biopsy
Verbruggen HW	-	The Importance of the Low-Density Lipoprotein Receptor-Related Protein (LRP) and Megalin Receptor in the Clearance of Factor VIII in Humans
	-	Administration of Recombinant Activated Factor VII Causes Activation of Integrin aIIbb3 on Blood Platelets both in vivo and in vitro, Lowering the Threshold for Activation by Thrombin
	-	Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients
Verdier M	-	Polymorphism A36G of the Tumor Necrosis Factor Receptor 1 Gene Is Associated with HDL Cholesterol, TNFR1 and PAI-1 Levels in Obese Women
	-	Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression
Vereb G	-	Comparison of Platelet Deposition on Collagen in Cone-And-Plate and Parallel Plate Flow Chambers
	-	Time Dependent Increase in Thrombus Size Formed under Flow Conditions upon Exposure to Collagen Correlates Inversely with Surface Expressed VWF
	-	A Novel Homozygous Mutation (1619delC) in GPIIb Gene Associated with Glanzmann Thrombasthenia, the Decay of GPIIb-mRNA and the Synthesis of a Truncated GPIIb Unable to Form Complex with GPIIIa
	-	Three Novel Heterozygous Mutations in a Patient with Type II Glanzmann Thrombasthenia
Vergnes C	-	Fibrinogen Variants of the Gamma Chain Coiled-Coil Portion Detected by Reverse Phase HPLC in Patients with Venous Thrombosis
	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
Vergura P	-	Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
	-	The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia
Verheyen K	-	Extended Thromboprophylaxis with Fondaparinux (Arixtra®) after Major Orthopedic Lower Limb Surgery: The EXPERT Study
Verheyen CCPM	-	Incidence of Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
Verheyen K	-	Use of Neuraxial Catheter for Anesthesia/Analgesia in Major Orthopedic Lower Limb Surgery Patients Treated With Prophylactic Doses of Fondaparinux (Arixtra®) in Routine Practice: The EXPERT Study
Verhoef S	-	Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow
Verkerk R	-	A Novel Coupled Enzymatic Assay for the Fast Kinetic Characterization of Synthetic and Physiological CPU (TAFIa) Substrates
Verlato F	-	Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study)
	-	Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study
	-	Utility Of D-Dimer in the Diagnosis of Deep Venous Thrombosis in Hospitalized Patients at High Risk of Venous Thromboembolism
Vermeulen HHM	-	A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest
Vermylen J	-	Macrophage-neutrophil Cross Talk During Pulmonary Exposure to Silica Particles Triggers Peripheral Platelet Activation Via Elastase
	-	The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure
	-	Domain A1 in Unfolded von Willebrand Factor Can Recruit Flowing Platelets to Collagen Surfaces Independently of Domain A3
	-	Thrombospondin-1 Secures Thrombus Adherence in vivo by Protecting (Sub)Endothelial VWF from Leavage by ADAMTS13
	-	Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G-protein Signaling 2 (RGS2)
Verschuren F	-	Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome
	-	Angiographic Documentation of the Efficacy of Recombinant Activated Factor VII (Novo Seven) to Control Diffuse Bleeding in Major Trauma
Versiero M	-	Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study
Verso M	-	Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study
	-	A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort
Verspyck E	-	Protein Z Polymorphisms, Protein Z Plasma Concentration and Severe Pre Eclampsia
Versteeg HH	-	Antithrombotics Inhibit Tumor Metastasis
	-	Signal Transduction by Tissue Factor – An Unusual Cytokine Receptor
	-	Coagulation Factors VIIa and Xa Promote Apoptosis in Human Tumor Cells in Association with CREB Activation
Versteeg HH	-	TF:FVIIa-Induced CREB Activation Occurs Via a Mechanism That Is Distinct from That Involved in TF:FVIIa-Induced STAT5 Activation
Vertrees J	-	Independent Qa Exercise to Validate Poc Coagulometer Reliability in Support of the Thinrs Trial and to Allay Perceptions of Possible Coagulometer Dysfunction
	-	Independent QA Exercise to Validate INR Test Strip Performance and Evaluate Perceptions of Excess Test Strip Error Messages in Support of the THINRS Trial
	-	Utility and Multi-site Acceptance of Patient Self-Reporting of INR Self-Test Results to a Central Database Utilizing a Computerized Interactive Voice Response System in the THINRS Study
Veszpremi A	-	Lack of P-selectin Glycoprotein Ligand-1 Protects Mice from Thrombosis after Thrombotic Challenges
Vetr H	-	Diagnosis of Acute Idiopathic Thrombotic Thrombocytopenic Purpura by Rapid Detection of ADAMTS 13 IgG Antibodies
Vetr H	-	TECHNOZYM® ADAMTS 13 Assays for Analyzing the vWF Cleaving Protease ADAMTS 13
Vettore S	-	High Prevalence of Cardiac Abnormalities in Patients with Congenital FV Deficiency
	-	Mutations in Homozygotes and Compound Heterozygotes with FXII Deficiency
	-	Non-Catheter Induced Venous Thrombosis in Haemophellia A E B Patients
Vey M	-	Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products
Vicaretti M	-	The Opposing Roles of Monocytes in Atherosclerosis
	-	The Circulating Progenitor in Intimal Hyperplasia: Could It Be the Fibrocyte?
Vicente MA	-	Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation
Vicente V	-	Conformational and Functional Changes in Antithrombin by Oxidation
	-	Pharmacogenetic Effect of Factor VII -323 Del/Ins Polymorphism on Diurnal Variation of Factor VII Coagulant Activity and INR in Steady Anticoagulated Patients with Atrial Fibrillation
	-	Protective Role of the Platelet GP IIIa Polymorphism HPA-1 (PlA) in Subarachnoid Hemorrhage
	-	Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic?
	-	Synergistic Association between Hypercholesterolemia and C46T Factor XII Polymorphism in the Development of Premature Myocardial Infarction
	-	Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome
	-	Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
Vicente MA	-	Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE)
Vicente V	-	Interaction of Selected Septin Proteins with Platelet Microtubules: Role in the Regulation of Platelet Exocytosis
	-	Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus
	-	Platelet Dysfunction Associated with Reduced Gai Expression in a family with Inherited Bleeding Disorder
	-	Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction
	-	Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy
	-	Ciclooxygenase-1 C50T Polymorphism Modulates the Thromboxane A2 Level and might Affect the Efficacy of Aspirin
	-	Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction
	-	Antagonism of TxA2 Receptor Plays a Major Role in the Inhibitory Effect of Flavonoids in Platelet Function
Vickers C	-	Diagnostic Dilemma of a Patient with Strong Lupus Anticoagulant and Intramuscular Haemorrhage, Requiring Treatment with Recombinant FVIIa
Vickers MA	-	ABO and Secretor Genotypes and the Risk of Pre-Eclampsia
Vidler V	-	Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A
	-	A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia
Vieira LM	-	Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients
	-	Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment
	-	Natural Anticoagulation Evaluation in Type 2 Diabetes
	-	Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes
Vieira LM	-	Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools?
Vieira LM	-	Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers
Viel KR	-	The Pharmacogenetics and Inhibitor Risk (PIR) Study: Do the Multiple Forms of Wildtype Factor (F)VIII Contribute to the Development of Anti-FVIII Antibodies in Hemophilia a Patients during Coagulation Factor Replacement Therapy?
Vielle B	-	Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome
Vielpeau C	-	Symptomatic Venous Thromboembolism and Mortality after Hip Fracture Surgery: The ESCORTE Study
Viera M	-	Anticoagulation Therapy in the Osteonecrosis
Viganò MG	-	The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma
Vigano' D'Angelo S	-	LMWH-Induced Thrombocytopenia (Type II) Successfully Treated with Fondaparinux (Arixtra®)
Vigh T	-	Extensive Venous Malformation Associated with Coagulation Abnormality: Treatment with Peginterferon Alfa 2a
Vigiani S	-	Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis
	-	Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes
Vigneau C	-	Thrombin Induced Upregulation of Plasminogen Activator Inhibitor 1 (PAI-1) is Mediated by a Pathway Including S100 A9 Ca++ Binding Protein
Vignoli A	-	ADAMTS-13 Activity Profile in Thrombotic Thrombocytopenic Purpura (TTP) Patients Prospectively Followed At A Single Centre
	-	Parallel Changes in Procoagulant Activity and Proangiogenic Capacity of Breast Cancer and Leukaemia Cells Exposed to All Trans Retinoic Acid (ATRA)
Vigorito E	-	Vav Family Proteins Are Required for Optimal Platelet Spreading on Fibrinogen
Vik A	-	Heparin Induces Release of Osteoprotegerin (OPG)
	-	Serum Osteoprotegerin in Young Survivors of Myocardial Infarction
Vilarrasa N	-	Effect of Cigarrette Smoking on Fibrinogen and Von Willebrand Factor and Their Association with Risk Factors for Microangiopathy
Villa M	-	Conjoint Analysis to Elicit Preferences on Anticoagulant Treatment in Patients Receiving Vitamin K Antagonists (VKA)
	-	Differences between Patients’, Physicians’ and Pharmacists’ Preferences for Treatment Products in Hemophilia. A Discrete Choice Experiment
Villa G	-	Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis
	-	Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
Villa P	-	Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
	-	Protein CValencia: Symptomatic Type II Protein C Deficiency Associated with a Mutation in the Gla Domain (Glu16 to Lys)
Villaça P	-	Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis
Villaça PR	-	Treatment of Extensive Venous Malformation-Associated Localized Intravascular Coagulation with Interferon-Alpha: Case Report
Villamil F	-	Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation
Villar A	-	Optimal Oral Anticoagulation Therapy and Major Bleeding in Patients with Heart Diseases in a Peruvian Heart Institute
	-	Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
	-	Surgery in Haemophilic Patients with Inhibitor
	-	Polipectomia in a Patient with a Moderate Congenital Deficiency of Factor V
Villard S	-	A Spot Peptide Approach to Identify Binding Regions Between the TF-FVIIa Complex and its Macromolecular Substrates FIX and FX
	-	Fine Epitope Mapping of Human Monoclonal Antibodies Directed Against the B Domain of Factor VIII
Villegas-Mendez A	-	EPCR Cleavage and inactivation by Neutrophil Proteinase 3
Villela MSH	-	Frequency of Anticardiolipin (aCL) Antibodies in Patients with Lupus Anticoagulant (LA) Detected by Different Methods: An Analysis of 4265 Cases
Villoutreix BO	-	Functional Analysis of the Factor Ix Egf-Like Domain Mutation Ile66thr Associated with Mild Hemophilia B
Vincelette J	-	Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism
Vincent J	-	Is the Maternal anti HPA-1a Antibody Concentration a Useful Parameter for Antenatal Management of High-risk Pregnancies?
Vincenzi D	-	Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update
Vinciguerra C	-	Genetic Study of 16 Women with Decreased FVIII Level and Assessment of Haemophilia a Carrier Status
Vinciguerra C	-	Combined Type 1 and Type 2N von Willebrand Disease: Contribution of Real Time PCR in Genotype Study
Viney E	-	Molecular Dissection of Platelet Production Via Random Mutagenesis
Vink H	-	Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers
Vink R	-	Thromboembolic and Bleeding Complications during Non-cardiac Surgery in Patients with Mechanical Heart Valves
Vinnikov I	-	Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System
Violi F	-	Thrombus Growth Is Mediated by Gp91phox
	-	Aspirin Does Not Equally Inhibit ThromboxaneA2 Formation in Long-Term Treated Patients
Virdis A	-	Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature
Virtanen KS	-	Limited Antiplatelet Effect of Clopidogrel In Aspirin-treated Patients with Coronary Artery Disease Associates with Cardiac Endpoints
Vishnubhotla P	-	Successful Management of Pregnancy in a Patient with Type III Von Willebrand Disease and Platelet Storage Pool Disorder
Viskov C	-	The New Anticoagulant Octaparin Displays High Antithrombotic Action in Venous Thrombosis in Rabbits and Rats without Impairment of Hemostasis
Vissac AM	-	A Novel, Specific and Quantitative Assay for Measuring Factor V-Leiden, with a Single Step Clotting Method
	-	Measurement of Hirudin and Synthetic Thrombin Inhibitors in Plasma with a New Clotting Method, without Interference of Clotting Factor Levels
	-	Binding of B2GP1 to Various Phospholipid Mixtures Is Calcium Dependent and Is Dramatically Enhanced by Antibodies: Understanding the Anticoagulant Paradox
	-	Antibodies to Phospholipid Cofactor Proteins Inhibit Their Binding to High Affinity Plps But Strongly Enhance Their Binding to Low Affinity Plps
Viswabandya A	-	Data From APTT Clot Curves of Automated Photo-Optical Coagulometers Correlates Better with Heterogeneity of Clinical Presentation in Severe Hemophilia A than FVIII: C Levels
	-	Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate®DVI
	-	Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin
Vitale G	-	Assessment of Protein S on Hepatopaths at the Last Stage
Vitale J	-	Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis
Vitale G	-	Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy
	-	Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy
Vitkovsky Y	-	Tissue Factor Expression and Proinflammatory Cytokines in Viral Hepatitis
Vitkovsky Y	-	Platelets Promote CD4+ Lymphocyte Adhesion to Extracellular Matrix and Fibronectin Under Flow: Role of Integrins, CD40 Ligand and P-Selectin Glycoprotein Ligand-1
	-	Influence of Interleukins on CD 4+ T-lymphocyte Adhesion to Extracellular Matrix in Presence of Platelets under Flow Condition
Vitkovsky Yu A	-	Comparative Analysis of the APC Resistance in East Siberian Residences
Vitsenya M	-	Homocystein and Hemostatic Variables in Young Postinfarction Patients
Viuff D	-	Effect of rFVIIa Following Experimental Hemodilution with Two Different Colloids in a Rabbit Cuticle Bleeding Model
Viviani L	-	D-Dimer Measurement after Acute Ischemic Stroke Does Not Predict Long Term Outcome Events
Vlahovic G	-	Pediatric Thrombosis
Vlodavsky I	-	Effect of Heparanase on TF Expression and TFPI Release
Voest EE	-	Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors
	-	The Interaction of Platelets-tumor Cell Complexes with Vitronectin
Vogt L	-	Absolute Risk of Arterial Thromboembolism (ATE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
Vogt C	-	Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
Vogt L	-	Absolute Risk of Venous Thromboembolism (VTE) Associated with Nephrotic Syndrome. Results from the Coltrane Study
Vogt A	-	Association between Platelet Function Analyzer 100 (PFA-100) Closure Times (CT), Bleeding Time (BT), Platelet Aggregation (PA), Blood Cell Counts, Fibrinogen, Factor VIII (FVIII) and Von Willebrand Factor (VWF)
	-	Reliability of Platelet Function Analyzer 100 (PFA-100™) Closure Times (CT) Induced by Collagen/Epinephrine (CO/EPI) and by Collagen/ADP (CO/ADP)
Voigt MW	-	TECHNOTHROMBIN® TGA a Novel Thrombin Generation Assay Suitable for the New Routine Coagulation Analyzer Ceveron® Alpha
Voinea M	-	VCAM-1 as Target for Immunoliposome-Mediated Drug Delivery to Activated Endothelial Cells
Voith B	-	Effect of Enoxaparin on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59-7939 – an Oral, Direct Factor Xa Inhibitor
Vojtech I	-	Hyperbaric Oxygen Therapy in Chronic Non-Healing Diabetic and Venous Ulcer
Volf I	-	Albumin Mildly Oxidized by the Myeloperoxidase Product Hypochlorous Acid Strongly Activates Platelets and Monocytes Via CD36
Völker U	-	Proteomics as a Tool for Assessment of Therapeutics in Transfusion Medicine: Evaluation of Prothrombin Complex Concentrates
Vollot F	-	Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
Vollset SE	-	Low Methionine Concentration as a Risk Factor for Recurrent Venous Thrombosis
Volot F	-	Management of Glanzmann's Thrombasthenia Surgery: Contribution of Thrombelastogram (ROTEM®)
Volot F	-	WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events
von Arbin M	-	Hemostatic and Inflammatory Disturbances are Present in Ischemic Stroke
Von Atzinger M	-	Effects of Leptospiral Proteins on Human Endothelial Cells
von Auer C	-	Extensive Venous Malformation Associated with Coagulation Abnormality: Treatment with Peginterferon Alfa 2a
Von Auer C	-	The Relation of Laboratory and Clinical Features to the Response to Plasma Exchange Therapy in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (TTP)
von Auer C	-	Epitope Mapping of Inhibitory Antibodies and Inhibitor Elimination with Rituximab in Patients with Acquired Haemophilia
von Auer C	-	Inhibitor Development in PTP's: A Retrospective Study in Germany
von Auer C	-	Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis
von Depka M	-	Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia
von Elverfeldt D	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
von Holt K	-	Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice
von Kummer R	-	Prophylaxis of Thromboembolic Complications in Acute Ischemic Stroke with the Low Molecular Weight Heparin Certoparin (PROTECT)
von Rosen J	-	A Baltic Origin of the Common ADAMTS13 Mutation 4143insA
von Tempelhoff GF	-	Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer – Results of the TOPIC Studies
von zur Muehlen C	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
von, Hertenstein B	-	Dose-dependent Platelet Activation and Microparticle Release by Different Clinical Antithymocyte Globulins
Voorberg J	-	Von Willebrand Factor-mediated Sorting of Endothelial Secretory Proteins
	-	Protein Kinase A-dependent Clustering of Weibel-Palade Bodies in Endothelial Cells
	-	Factor VIII Inhibitors in Hemophilia A during Immune Tolerance Induction
Vora S	-	Prevalence of Thrombophilic Mutations and Polymorphisms in Cases of Recurrent Pregnancy Loss (RPL)
Vorlova Z	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
Vormittag R	-	High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma
Vormittag R	-	High Levels of Anti-protein Z Immunoglobulin G and M Antibodies, Persistent Lupus Anticoagulant and Thrombosis
	-	C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
Vormittag R	-	Thrombophilia and Pregnancy Outcomes
Vormittag R	-	Favourable Pregnancy Outcome in Women with a History of Venous Thromboembolism and Prophylactic Low Molecular Weight Heparin (LMWH)
Voros G	-	Modulation of Angiogenesis during Adipose Tissue Development in Murine Models of Obesity
Vos HL	-	The Association of Prothrombin A19911G Polymorphism with Plasma Prothrombin Activity and Venous Thrombosis in a Large Population-Based Case-Control Study; Results of the MEGA Study
	-	The Marburg I Polymorphism of Factor Seven-Activating Protease Is Not Associated with Venous Thrombosis
	-	MTHFR C677T and the Risk Of Venous Thrombosis – Interaction with Factor V Leiden and Prothrombin G20210A Mutations
	-	Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
	-	Interleukin 1 Haplotypes and the Risk of Venous Thrombosis
Vos HL	-	Alignment of Factor V Sequences in Twelve Mammalian Species Shows Several Strongly Conserved Motifs in the B-Domain
Vos HL	-	The Prothrombin G19911A Is a Functional Non-coding Polymorphism
	-	Association of Coagulation Factor VIII Haplotypes with Factor VIII Activity and the Risk of Venous and Arterial Thrombosis
	-	ABO Blood Group Genotypes and the Risk of Venous Thrombosis: Effect of Factor V Leiden
	-	The Effect of ABO Blood Group Genotypes on the Loading of von Willebrand Factor with A and B Antigens
	-	Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
Vos HL	-	A Database of Deficiency-Causing Mutations and Polymorphisms in the Factor V Gene
	-	Haplotypes of the Fibrinogen Genes, Plasma Fibrinogen Levels and the Risk of Deep Venous Thrombosis
Voss H	-	Platelet Activation Markers and Procoagulant Phenotype of Monocytes do Correlate with Markers of Reperfusion Injury Following Reperfusion after Orthotopic Liver Transplantation
Vossen CY	-	Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
Vossen CY	-	Attitudes about Genetic Testing for Thrombophilia in a Large Family with Heritable Protein C Deficiency
Vossen CY	-	Linkage Analysis Reveals No Evidence for Loci Other than the Factor VII Gene Influencing Factor VII Levels
	-	Evidence for Loci Pleotropically Influencing Inter-Related Clotting Factors
Voznyuk V	-	Vascular Complications at Patients with Polycythemia Vera: Interrelation between Endothelial Dysfunction and Haemostasis Disorders
Voznyuk V	-	The Role of Mild Forms of Coagulopathias and Pathology of Platelets in the Development of Menorrhagia and Metrorrhagia
	-	The Role of Mild Forms of Coagulopathias and Pathology of Platelets in the Development of Menorrhagia and Metrorrhagia
Voznyuk V	-	Vascular Complications at Patients with Polycythemia Vera: Interrelation Between Endothelial Dysfunction and Haemostasis Disorders
Váradi K	-	Kinetics of in vivo Activation of Protein C In Healthy Animals
	-	Thrombin Generation Assay – A Sensitive Tool to Follow the Pharmacokinetics of Factor VIII Replacement Therapy in Haemophilia Patients
	-	Applications of Thrombin Generation Assay in Characterizing FVIII Bypassing Agents
Vrints CJ	-	Pretreatment with Aspirin and Loading Dose Clopidogrel Obviates the Need for Glycoprotein Iib/Iiia Antagonists During Elective Coronary Stenting
Vroom M	-	Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs
Vu D	-	Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion
	-	Heterozygosity for a Novel FGG Trp253Cys Mutation Causes Hypofibrinogenemia by Specifically Impairing Fibrinogen Secretion
Vu L	-	Efficacy of the PFA-100® as a Screening Tool for Platelet Dysfunction
Vught M	-	Coagulation Disorders in Severe leptospirosis in Indonesia
Vukcevic V	-	Homocysteine Levels and MTHFR C677T Genotypes in Patients with Myocardial Infarction under Age 45 years
Vukovich T	-	C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
Vural O	-	The Prevalence of Von Willebrand's Disease in Trakya Region of Turkey
Vyas H	-	Effectiveness of Recombinant Activated FVII (rFVIIa) for the Treatment of Severe Bleeding Episodes in Pediatric Patients
Vystavkin AI	-	The Effect of TFPI On Thrombin Generation: a Mathematical Model